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Neurobiological circuit function and
computation of the serotonergic and related
systems
In this research topic, Herzallah et al.
(2013) have contributed original work,
exploring the effects of Major Depressive
Disorder (MDD) and of treatment with
a selective serotonin reuptake inhibitor
(SSRI) on responses in a reinforcement-
learning task. The task developed by the
authors allows for dissociation between
positive (reward) and negative (punish-
ment) reinforcement learning and was
used to compare, in a cross-sectional
design, healthy controls (HC), patients
with MDD prior to initiating treatment
(MDD), and patients recovered from
MDD under treatment with paroxetine
(a SSRI; MDD-T). The main finding of
their work was that, when compared to
HC, patients with untreated MDD were
impaired in reward learning, while MDD
patients under treatment with paroxetine
were impaired in both reward and punish-
ment learning. As a result of these response
profiles, the relative learning from reward
and punishment was similar between HC
and MDD-T (due to blunted responses to
both valences in MDD-T) while, in MDD
patients, learning from negative feedback
was exaggerated when compared to learn-
ing from positive reinforcement.
The findings reported in this paper
(Herzallah et al., 2013) contribute novel
insights to the body of literature explor-
ing the relationship between depression,
reinforcement and serotonin (5-HT). The
interest on understanding reinforcement
processes in the context of depression is
sustained on the fact that anhedonia, i.e.,
the loss of interest or pleasure in all or
almost all activities, is a key-symptom
of MDD (APA Task Force on DSM-IV,
1994). Preclinical analogs to anhedonia,
commonly used to assess depression-like
behavior in rodents, are the sucrose intake
and preference tests, whereby decreased
intake of, or preference for, a sweet sucrose
solution (relative to water) are argued to
reflect an anhedonic state (Monleon et al.,
1995). The relationship between seroton-
ergic processing and depression has been
suggested mostly from the anti-depressant
effects of drugs modulating serotonergic
neurotransmission (Shopsin et al., 1976;
Delgado et al., 1990). Recently, several
hypotheses have been put forward to sug-
gest that the link between MDD and 5HT
might be indirect and mediated by asso-
ciative learning (Robinson and Sahakian,
2008) and/or disinhibition of negative
thoughts (Dayan and Huys, 2008). Elliott
et al. (1996), for example, found that dur-
ing application of a neuropsychological
assessment battery, after having solved one
problem incorrectly, MDD patients were
more likely than controls to fail the sub-
sequent problem. This finding correlated
with the severity of the depression and
has been interpreted as oversensitivity to
negative feedback.
Several paradigms have been used
to explore the processing capabilities of
depressed patients in contexts of reward
and/or punishment. Findings have not
been entirely consistent, possibly due
to heterogeneity of patient samples and
differences in testing protocols, with
different authors suggesting that patients
with MDD have more significant deficits
in reward learning (Henriques and
Davidson, 2000; Pizzagalli et al., 2008;
McFarland and Klein, 2009; Robinson
et al., 2012) punishment learning (Murphy
et al., 2003; Santesso et al., 2008) or
both (Must et al., 2006). Henriques and
Davidson (2000) compared MDD patients
to a group of non-depressed control sub-
jects on a verbal memory task under
three monetary payoff conditions: neutral,
reward, and punishment. While control
subjects maximized their earnings by
modulating their pattern of response in
both reward and punishment conditions,
relative to the neutral condition, depressed
subjects did not do so during reward.
Others (McFarland and Klein, 2009) have
reported similar findings, with reactiv-
ity in response to anticipated reward
being significantly diminished in currently
depressed compared with never depressed
participants, and marginally diminished
in comparison with previously depressed
participants. There is also evidence to
suggest exaggerated responses to punish-
ment in MDD, rather than diminished
responses to reward. In a study based on
a probability reversal task (Murphy et al.,
2003), when given misleading negative
feedback, MDD patients were impaired in
the ability to maintain the response set,
as shown by their increased tendency to
switch responding to the ’incorrect’ stim-
ulus following negative reinforcement,
relative to controls.
Others have compared neural responses
to stimuli with positive and negative
valence between depressed and non-
depressed volunteers. McCabe et al. (2009)
compared unmedicated patients with
a history of major depression to age
and gender matched HC. Despite no
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differences in stimulus ratings, recovered
patients had decreased neural responses
to the pleasant stimulus in the ven-
tral striatum and increased responses
in the caudate nucleus to the aversive
stimulus. The same authors (McCabe
et al., 2010) later found that citalopram
(a SSRI antidepressant), but not rebox-
etine (another antidepresssant that acts
as a noradrenaline reuptake inhibitor),
reduced activation from rewarding stimuli
in the ventral striatum and orbitofrontal
cortex. Citalopram also decreased neu-
ral responses to the aversive stimuli
conditions in areas such as the lateral
orbitofrontal cortex, while reboxetine pro-
duced a similar, although weaker, effect.
Others have found that another antide-
pressant (duloxetine, a dual serotonin and
noradrenaline reuptake inhibitor), rather
than diminishing the neural processing of
both rewarding and aversive stimuli, can
increase ventral striatal activity in humans
(Ossewaarde et al., 2011).
The findings now reported byHerzallah
et al. (2013) highlight the importance of
considering treatment effects when testing
the relationship between depression and
reinforcement learning. Furthermore, the
authors provide behavioral support for
the neural findings previously described
by McCabe et al. (McCabe et al., 2010):
in both cases responses to reward and
punishment were reduced by treatment
with a SSRI, possibly accounting for the
experience of emotional blunting described
by some patients during SSRI treatment
(Price et al., 2009). However, as is acknowl-
edged by the authors (Herzallah et al.,
2013), these findings should be interpreted
in the context of their cross-sectional
study design. For example, it is unclear
if, before starting treatment, disease sever-
ity in MDD-T patients was similar to that
found in MDD patients, and also if the
latter group will respond to treatment sim-
ilarly to the MDD-T group. Importantly,
because MDD-T patients are responders
to treatment, the experimental design also
does not distinguish entirely between the
effects of paroxetine per se and the effects
of recovery from depression. Future work,
with a longitudinal study design and/or
including groups at different phases of
treatment or treated with non-SSRI drugs
or non-pharmacological alternatives,
should address these questions.
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